Notably, hyperaldosteronism is a common feature of CKD.42 Therefore, FGF23-induced volume expansion in CKD does not suppress RAAS activity but rather contributes to a vicious cycle of volume overload, blood pressure increase, glomerular hyperfiltration and ultimately, nephron loss. Here, FGF23 is linked to chronic kidney disease.